Oct and Imaging in Central Nervous System Diseases: The Eye as a Window to the Brain (中央神經系統疾病中的光學相干斷層掃描：眼睛作為通往大腦的窗口)

Grzybowski, Andrzej, Barboni, Piero

Oct and Imaging in Central Nervous System Diseases: The Eye as a Window to the Brain
  • 出版商: Springer
  • 出版日期: 2025-02-14
  • 售價: $7,720
  • 貴賓價: 9.5 折 $7,334
  • 語言: 英文
  • 頁數: 800
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 3031721551
  • ISBN-13: 9783031721557

    • 尚未上市，無法訂購

相關主題

商品描述

This book offers a current overview of state-of-the-art advances using optical coherence tomography (OCT) re-grading neuronal loss within the retina. Detailed information on the OCT imaging and interpretation is provided for the evaluation of disease progression in numerous neurodegenerative disorders and as a biological marker of neuroaxonal injury. Covering disorders like multiple sclerosis, Parkinson's disease, Alzheimer's disease, intracranial hypertension, Friedreich's ataxia, schizophrenia, hereditary optic neuropathies, glaucoma, and amblyopia, readers will be given insights into effects on the retina and the and optic nerve. Individual chapters are also devoted to OCT technique, new OCT technology in neuro-ophthalmology, OCT and pharmacological treatment, and the use of OCT in animal models.

OCT and Imaging in Central Nervous System Diseases, 3rd Edition is a richly illustrated reference for the diagnosis of many retinal diseases and monitoring of surgical and medical treatment. By documenting the ability of OCT to provide key information on CNS diseases, this book illustrates convincingly that the eye is indeed the "window to the brain".


商品描述(中文翻譯)

本書提供了使用光學相干斷層掃描（OCT）重新評估視網膜神經元損失的最新進展概覽。書中詳細介紹了OCT影像及其解讀，以評估多種神經退行性疾病的病程進展，並作為神經軸突損傷的生物標記。涵蓋的疾病包括多發性硬化症、帕金森氏症、阿茲海默症、顱內高壓、弗里德里希共濟失調、精神分裂症、遺傳性視神經病、青光眼和弱視，讀者將深入了解這些疾病對視網膜和視神經的影響。各章節還專門討論了OCT技術、神經眼科的新OCT技術、OCT與藥物治療，以及OCT在動物模型中的應用。

《OCT與中樞神經系統疾病影像學》第三版是一本豐富插圖的參考書，適用於許多視網膜疾病的診斷及手術和醫療治療的監測。通過記錄OCT在中樞神經系統疾病中提供關鍵資訊的能力，本書有力地說明了眼睛確實是通往大腦的“窗口”。

作者簡介

Andrzej Grzybowski MD, PhD, MBA, is a Professor of Ophthalmology and Chair of the Department of Ophthalmology at the University of Warmia and Mazury, Olsztyn, Poland and the Head of Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland.

Professor Grzybowski has been an editor, editor-in-chief, and author of more than 500 peer-reviewed international publications (total IF higher than 1000), and over 50 book's chapters and reviewer for more than 20 journals. He is a member of editorial boards of American Journal of Ophthalmology, Acta Ophthalmologica, PLOS One, Graefe's Archive for Clinical and Experimental Ophthalmology, Translational Vision Science and Technology (TVST), BMC Ophthalmology, Clinics in Dermatology, Journal of Clinical Medicine, Frontiers in Neurology, Asia Pacific Academy of Ophthalmology Journal, and editor in chief of Archives of History and Philosophy of Medicine and Historia Ophthalmologica Internationalis.

He was included in TOP 2% ranking of world-best scientists prepared by Stanford University for 2019, and according to Expertscape, he was ranked No 1 in cataract field worldwide and No 4 in cataract extraction field worldwide. He has authored and conducted the largest European diabetic retinopathy screening project based on artificial intelligence aimed to test 40,000 diabetic patients sponsored by EU funds. He collaborates in AI projects with leading European, US, and Asian scientific teams.

Piero Barboni, MD, graduated in Medicine and Surgery from the University of Bologna, Italy, in 1986 and went on to complete his Specialization in Ophthalmology at the same university in 1990. After spending almost two decades in private practice, he was appointed Professor of Neuro-ophthalmology in the Department of Neurological Science, Bologna University. Since 2012 Dr. Barboni has been a Consultant Ophthalmologist at the Scientific Institute San Raffaele, University of Milan. His memberships include the Association for Research in Vision and Ophthalmology (ARVO) and the North American Neuro-Ophthalmology Society (NANOS). Dr. Barboni has been sub-investigator in many clinical trials on good clinical practice in multiple sclerosis and is a participant in an international research project on Leber's hereditary optic neuropathy. He is the author of more than 70 articles in peer-reviewed journals.



作者簡介(中文翻譯)

安德烈茲·格日博斯基（Andrzej Grzybowski）醫學博士、哲學博士、工商管理碩士，是波蘭奧爾什丁的瓦爾米亞和馬祖里大學眼科教授及眼科系主任，同時也是波茲南眼科發展基金會眼科研究所的所長。

格日博斯基教授擔任過編輯、主編，並發表了超過500篇經過同行評審的國際出版物（總影響因子超過1000），以及超過50章書籍的章節，並為超過20本期刊擔任審稿人。他是《美國眼科期刊》（American Journal of Ophthalmology）、《眼科學報》（Acta Ophthalmologica）、《PLOS One》、《格拉費臨床與實驗眼科檔案》（Graefe's Archive for Clinical and Experimental Ophthalmology）、《轉化視覺科學與技術》（Translational Vision Science and Technology, TVST）、《BMC眼科》（BMC Ophthalmology）、《皮膚科臨床》（Clinics in Dermatology）、《臨床醫學期刊》（Journal of Clinical Medicine）、《神經學前沿》（Frontiers in Neurology）、《亞太眼科學會期刊》（Asia Pacific Academy of Ophthalmology Journal）的編輯委員會成員，並擔任《醫學史與哲學檔案》（Archives of History and Philosophy of Medicine）及《國際眼科歷史學》（Historia Ophthalmologica Internationalis）的主編。

他在2019年被史丹佛大學列入全球最佳科學家前2%的排名，根據Expertscape的資料，他在全球白內障領域排名第一，在白內障手術領域排名第四。他是基於人工智慧的歐洲最大糖尿病視網膜病變篩檢計畫的作者和負責人，該計畫旨在測試40,000名糖尿病患者，並由歐盟資助。他與歐洲、美國和亞洲的領先科學團隊合作進行人工智慧項目。

皮耶羅·巴爾博尼（Piero Barboni）醫學博士，1986年畢業於意大利博洛尼亞大學醫學與外科學，並於1990年在同一所大學完成眼科專業訓練。在私人執業近二十年後，他被任命為博洛尼亞大學神經眼科教授。自2012年以來，巴爾博尼博士一直擔任米蘭大學聖拉斐爾科學研究所的顧問眼科醫生。他是視覺與眼科研究協會（ARVO）和北美神經眼科學會（NANOS）的成員。巴爾博尼博士曾在多發性硬化症的良好臨床實踐臨床試驗中擔任副研究員，並參與一項關於勒貝氏遺傳性視神經病的國際研究項目。他在同行評審的期刊上發表了超過70篇文章。

類似商品